Craig Hallum began coverage on shares of Teladoc Inc. (NYSE:TDOC) in a note issued to investors on Monday. The brokerage set a “buy” rating on the stock.
Other analysts also recently issued research reports about the stock. FBR & Co decreased their target price on shares of Teladoc from $34.00 to $28.00 and set an “outperform” rating for the company in a research report on Thursday, August 4th. Deutsche Bank AG decreased their target price on shares of Teladoc from $21.00 to $20.00 and set a “buy” rating for the company in a research report on Thursday, August 4th. Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $24.00 target price (down previously from $25.00) on shares of Teladoc in a research report on Friday, August 5th. Zacks Investment Research downgraded shares of Teladoc from a “hold” rating to a “sell” rating in a research report on Tuesday, September 20th. Finally, Piper Jaffray Cos. reissued an “overweight” rating and set a $21.00 target price (down previously from $22.00) on shares of Teladoc in a research report on Friday, August 5th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and eleven have assigned a buy rating to the company’s stock. Teladoc presently has an average rating of “Buy” and a consensus target price of $22.91.
Shares of Teladoc (NYSE:TDOC) traded up 0.138% during mid-day trading on Monday, hitting $18.175. 80,294 shares of the stock were exchanged. The stock’s 50 day moving average price is $16.69 and its 200-day moving average price is $15.86. Teladoc has a 12-month low of $9.08 and a 12-month high of $22.00. The stock’s market capitalization is $836.63 million.
Teladoc (NYSE:TDOC) last released its quarterly earnings data on Thursday, October 27th. The company reported ($0.33) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.36) by $0.03. Teladoc had a negative return on equity of 32.68% and a negative net margin of 69.15%. The company earned $32.40 million during the quarter, compared to the consensus estimate of $32.29 million. During the same quarter in the prior year, the firm posted ($0.35) earnings per share. The firm’s revenue was up 62.0% compared to the same quarter last year. On average, equities research analysts expect that Teladoc will post ($1.42) EPS for the current fiscal year.
In related news, VP Mark Hirschhorn sold 5,000 shares of the stock in a transaction on Monday, October 17th. The stock was sold at an average price of $15.52, for a total value of $77,600.00. Following the transaction, the vice president now directly owns 268,387 shares in the company, valued at approximately $4,165,366.24. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. 5.94% of the stock is owned by corporate insiders.
Institutional investors have recently modified their holdings of the company. Capital World Investors boosted its position in shares of Teladoc by 186.7% in the third quarter. Capital World Investors now owns 3,295,269 shares of the company’s stock worth $60,336,000 after buying an additional 2,146,021 shares in the last quarter. Peregrine Capital Management LLC bought a new position in shares of Teladoc during the third quarter valued at $13,106,000. Sectoral Asset Management Inc. boosted its position in shares of Teladoc by 50.1% in the second quarter. Sectoral Asset Management Inc. now owns 1,464,221 shares of the company’s stock valued at $23,457,000 after buying an additional 488,688 shares during the period. EverPoint Asset Management LLC bought a new position in shares of Teladoc during the second quarter valued at $5,207,000. Finally, Tamarack Advisers LP bought a new position in shares of Teladoc during the third quarter valued at $5,818,000. Institutional investors own 53.34% of the company’s stock.